Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Post by Liked2Thinkon May 11, 2021 5:51pm
246 Views
Post# 33179092

What will Actually Raise this SP

What will Actually Raise this SPThe only thing and its obvious now is the thing every investor was expected with Aristotles release.

A large health care provide to team with Stage.  You know the thing Tripp has always talked about.

This is more important than dollar amount this would give Stage actual support from a reputable company.  It would prove the technolgy is good and there is a market for it.

What we are seeing is the consequences of past mistakes catching up with the management during a time they should be flying higher than ever.  This price is a reflection that the market is fed up with the BS and even good news is meaningless now.

Just think if the NR had just said "Aritstotle Officially Released" back on Apr 1.  Thats literally all it needed to say.  No mention of anything else.  We would be a dollar higher today than we are now.

It is going to take momumental news.  


<< Previous
Bullboard Posts
Next >>